Creative Biotherapeutics LLC
Gurnee, IL
- UEI
- YNJ8ST14PBD8
- CAGE
- 7NJE6
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 4835 Kings Way W, Gurnee, IL 60031, USA
- Website
- creativebio.tech
- Founded
- 2016
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Senex Biotechnology Inc. | Maynard, MA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Akanocure Pharmaceuticals Inc. | West Lafayette, IN | — |
| Dotquant LLC | Shoreline, WA | — |
| Invvax, Inc. | Cypress, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Endomimetics, Inc. | Birmingham, AL | — |
About the company
Creative Biotherapeutics LLC is a for-profit limited liability company registered in SAM.gov since April 2016, specializing in advanced biotherapeutic research and development focused on innovative medical treatments for complex diseases. The company appears to be a biotechnology research firm that develops novel therapeutic approaches targeting challenging medical conditions, with a particular emphasis on cancer and viral infection treatments. Their core competency involves developing innovative biologic therapies that address drug-resistant cancers and viral infections by targeting specific cellular stress pathways and proteins.
The company has received significant federal grant awards from civilian agencies, primarily the National Cancer Institute (NCI) and National Science Foundation (NSF), focusing on groundbreaking medical research. Their recent federal grant awards include a $800,000 NCI project grant to develop a novel biologic therapy for eradicating brain cancer and brain metastases, which demonstrated promising preclinical results with over 65% pathological complete responses in mouse models. Additionally, they received NSF grants totaling approximately $255,700 for COVID-19 research, specifically developing inhibitors to prevent viral infection by blocking cellular stress pathways. Their research aims to create non-toxic therapeutic alternatives that can potentially transform treatment approaches for brain cancers, metastatic diseases, and viral infections like SARS-CoV-2, with a unique focus on targeting proteins like extracellular glucose-regulated protein 78 (eGRP78) to induce apoptosis in drug-resistant tumor cells and block viral infection mechanisms.
Quick answers
Is Creative Biotherapeutics LLC registered in SAM.gov?
Yes. Creative Biotherapeutics LLC's SAM.gov registration is active through June 15, 2027.
What is Creative Biotherapeutics LLC's most recent federal award?
Creative Biotherapeutics LLC's most recent federal grant award is Developing a novel biologic therapy to eradicate brain cancer and brain metastasis (R43CA295180), from National Cancer Institute (NIH), on September 1, 2024.
On GovTribe
See Creative Biotherapeutics LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors